Viperin Inhibits Hepatitis C Virus Replication by Interfering with Binding of NS5A to Host Protein Hvap-33

Shanshan Wang,Xianfang Wu,Tingting Pan,Wuhui Song,Yaohui Wang,Fei Zhang,Zhenghong Yuan
DOI: https://doi.org/10.1099/vir.0.033860-0
2011-01-01
Journal of General Virology
Abstract:Viperin is a type-I and -II interferon-inducible intracytoplasmic protein that mediates antiviral activity against several viruses. A previous study has reported that viperin could limit hepatitis C virus (HCV) replicationin vitro. However, the underlying mechanism remains elusive. In the present study, we found that overexpression of viperin could inhibit HCV replication in a dose-dependent manner in both the replicon and HCVcc systems. Furthermore, through co-immunoprecipitation and laser confocal microscopic analysis, viperin was found to interact with the host protein hVAP-33. Mutagenesis analysis demonstrated that the anti-HCV activity of viperin was located to its C terminus, which was required for the interaction with the C-terminal domain of hVAP-33. Competitive co-immunoprecipitation analysis showed that viperin could interact competitively with hVAP-33, and could therefore interfere with its interactions with HCV NS5A. In summary, these findings suggest a novel mechanism by which viperin inhibits HCV replication, possibly through binding to host protein hVAP-33 and interfering with its interaction with NS5A.
What problem does this paper attempt to address?